Elucidating the Molecular and Functional Diversity of Axial Motor Neurons
Project Number1F32HD116654-01
Contact PI/Project LeaderADAMS, ALEXANDRA A
Awardee OrganizationNEW YORK UNIVERSITY SCHOOL OF MEDICINE
Description
Abstract Text
Project Summary/Abstract
The axial neuromuscular system plays a critical role in many essential motor behaviors in mammals, including
breathing, postural stability, and integration of movement by the trunk and limbs. While the mechanisms that
allow for molecular and functional diversification of limb innervating motor neurons (MN) have been relatively
well characterized, less is understood about how axial motor circuits are specified during development. Further,
it is not well understood whether axial MNs exist in discrete pools that innervate distinct muscle populations to
achieve motor activities through activation of specific muscles. It is also not known whether the molecular
identities of axial motor neurons are related to a set of functional properties in tetrapods, nor if these molecular
identities dictate the connectivity patterns of spinal premotor interneurons that modulate activity of downstream
muscle targets. The proposed work in this study seeks to elucidate the fate determinants that govern organization
of molecularly distinct populations of motor neurons within the medial motor column (MMC). In Aim1, I will
characterize the molecular subtypes and anatomical organization of MMC neurons. I will use single nuclear (sn)
RNA-seq to define the molecular diversity of MMC MNs in mouse embryos. I will then use immunohistochemistry
(IHC) and hybridization chain reaction RNA-FISH (HCR) to further characterize the anatomical organization of
molecularly defined MNs. I will also use retrograde tracing in embryos and early postnatal mice to determine
whether molecularly unique populations of MMC neurons correspond to motor pools. Aim 2 explores the role of
fate determinants in axial MN diversity and muscle target specificity. I will use snRNA-seq, IHC and HCR to map
the molecular diversity and organization of MMC MNs in mice with mutations in three classes of fate
determinants, Mecom/Prdm16, Satb2, and Lhx3/4. Further, I will use mice that co-express the Hb9-GFP reporter
to assess the pattern of axial muscle innervation. Finally, to define the epistatic relationships between these
transcription factors in the MMC gene network, I will use chick neural tube electroporation to misexpress Mecom,
Satb2 or Lhx3 in all MNs and examine the impact on axial MN specification. Aim 3 seeks to elucidate the role of
MMC molecular identity in axial circuit assembly and function. I will use monosynaptic rabies tracing to define
the distribution of spinal premotor inputs targeting MMC in control and mutant mouse models. I will also perform
motorized treadmill assays while recording muscle activity from epaxial muscle, in addition to capturing gait and
posture during locomotion. This work will provide an understanding of how axial motor systems are developed,
their functions, the molecular identity of unique axial motor pools, and the role of fate determinants in specifying
circuits that dictate the function of axial muscle. Understanding this is essential to our understanding of the
function of axial MNs and their larger role in spinal cord injury and disease. Further, this project could serve as
a model for childhood developmental disorders such as scoliosis.
Public Health Relevance Statement
Project Narrative
The primary goal of this project is to investigate the molecular mechanisms involved in the assembly of spinal
circuits governing posture and locomotion. This study will explore the role of cell fate determinants in
establishing synaptic specificity in the axial neuromuscular system and determine how developmental
programs contribute to the emergence of specific motor behaviors. Defining the pathways that regulate axial
motor circuit development provide basic insights relevant to the study of diseases that affect motor control,
including developmental disorders in humans such as scoliosis.
Eunice Kennedy Shriver National Institute of Child Health and Human Development
CFDA Code
865
DUNS Number
121911077
UEI
M5SZJ6VHUHN8
Project Start Date
10-September-2024
Project End Date
09-September-2027
Budget Start Date
10-September-2024
Budget End Date
09-September-2025
Project Funding Information for 2024
Total Funding
$76,756
Direct Costs
$76,756
Indirect Costs
Year
Funding IC
FY Total Cost by IC
2024
Eunice Kennedy Shriver National Institute of Child Health and Human Development
$76,756
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1F32HD116654-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1F32HD116654-01
Patents
No Patents information available for 1F32HD116654-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1F32HD116654-01
Clinical Studies
No Clinical Studies information available for 1F32HD116654-01
News and More
Related News Releases
No news release information available for 1F32HD116654-01
History
No Historical information available for 1F32HD116654-01
Similar Projects
No Similar Projects information available for 1F32HD116654-01